Role of white matter lesions, cerebral atrophy, and APOE on cognition in older persons with and without dementia: the Cache County, Utah, study of memory and aging.

Neuropsychological, qualitative, and quantitative magnetic resonance imaging findings were examined in subjects with Alzheimer's disease (AD), non-AD dementia or mixed neuropsychiatric disorder, subjects characterized as mild/ambiguous, and controls, all with known apolipoprotein E (APOE) genotype. Neuropsychological tasks included an expanded Consortium to Establish a Registery for Alzheimer's Disease (J. T. Tschanz et al., 2000; K. A. Welsh, J. M. Hoffman, N. L. Earl, & M. W. Hanson 1994) battery and the Mini-Mental Status Examination (M. F. Folstein, S. E. Folstein, & P. R. McHugh, 1975). Periventricular white matter lesions were the most clinically salient, and generalized measures of cerebral atrophy were the most significant quantitative indicators. APOE genotype was unrelated to imaging or neuropsychological performance. Neuropsychological relationships with neuroimaging findings depend on the qualitative or quantitative method used.

[1]  Irene Daum,et al.  Narcolepsy: Pathophysiology and Neuropsychological Changes , 2003, Behavioural neurology.

[2]  Jeff Victoroff,et al.  White Matter Lesions, Quantitative Magnetic Resonance Imaging, and Dementia , 2002, Alzheimer disease and associated disorders.

[3]  Erin D Bigler,et al.  Temporal lobe morphology in normal aging and traumatic brain injury. , 2002, AJNR. American journal of neuroradiology.

[4]  R Kikinis,et al.  Older people with impaired mobility have specific loci of periventricular abnormality on MRI , 2002, Neurology.

[5]  Hiroaki Kazui,et al.  Apolipoprotein E ε4 and the pattern of regional brain atrophy in Alzheimer’s disease , 2001, Neurology.

[6]  G Ratcliff,et al.  Patterns of cognitive decline in presymptomatic Alzheimer disease: a prospective community study. , 2001, Archives of general psychiatry.

[7]  D F Tate,et al.  Brain Volume, Intracranial Volume, and Dementia , 2001, Investigative radiology.

[8]  Robert H. Paul,et al.  Single Photon Emission Computed Tomography, Magnetic Resonance Imaging Hyperintensity, and Cognitive Impairments in Patients With Vascular Dementia , 2001, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

[9]  MD J.C. de Groot,et al.  Cerebral white matter lesions and subjective cognitive dysfunction , 2001, Neurology.

[10]  C. Reynolds,et al.  Relationship of deep white matter hyperintensities and apolipoprotein E genotype to depressive symptoms in older adults without clinical depression. , 2001, The American journal of psychiatry.

[11]  R. Graves,et al.  Statistical Power and Effect Sizes of Clinical Neuropsychology Research , 2001, Journal of clinical and experimental neuropsychology.

[12]  E. Kaplan,et al.  Boston Naming Test , 2001 .

[13]  E. Bigler,et al.  Dementia, quantitative neuroimaging, and apolipoprotein E genotype. , 2000, AJNR. American journal of neuroradiology.

[14]  Mark S. Cohen,et al.  Patterns of brain activation in people at risk for Alzheimer's disease. , 2000, The New England journal of medicine.

[15]  E. Tangalos,et al.  Low mini-mental status predicts mortality in asymptomatic carotid arterial stenosis , 2000, Neurology.

[16]  H C Charles,et al.  Hippocampal sulcal cavities on MRI: Relationship to age and apolipoprotein E genotype , 2000, Neurology.

[17]  B W Wyse,et al.  Prevalence of depression and its treatment in an elderly population: the Cache County study. , 2000, Archives of general psychiatry.

[18]  A. Fagan,et al.  Apolipoprotein E facilitates neuritic and cerebrovascular plaque formation in an Alzheimer's disease model , 2000, Annals of neurology.

[19]  B. Winblad,et al.  The course of cognitive impairment in preclinical Alzheimer disease: three- and 6-year follow-up of a population-based sample. , 2000, Archives of neurology.

[20]  Roberta F. White,et al.  The preclinical phase of alzheimer disease: A 22-year prospective study of the Framingham Cohort. , 2000, Archives of neurology.

[21]  S. DeKosky,et al.  Apolipoprotein E polymorphism and Alzheimer disease: The Indo-US Cross-National Dementia Study. , 2000, Archives of neurology.

[22]  L. Kuller,et al.  Estrogen use, APOE, and cognitive decline , 2000, Neurology.

[23]  S. Wisniewski,et al.  Severity of cognitive impairment and the clinical diagnosis of AD with Lewy bodies , 2000, Neurology.

[24]  A. Hofman,et al.  Atrial fibrillation and the risk of cerebral white matter lesions , 2000, Neurology.

[25]  D. Zaitchik,et al.  Predicting conversion to Alzheimer disease using standardized clinical information. , 2000, Archives of neurology.

[26]  R. Gilmore,et al.  Electroencephalographic, volumetric, and neuropsychological indicators of seizure focus lateralization in temporal lobe epilepsy. , 2000, Archives of neurology.

[27]  Faith M. Gunning-Dixon,et al.  The cognitive correlates of white matter abnormalities in normal aging: a quantitative review. , 2000, Neuropsychology.

[28]  R. Killiany,et al.  Use of structural magnetic resonance imaging to predict who will get Alzheimer's disease , 2000, Annals of neurology.

[29]  J. Mugler,et al.  White matter abnormalities in mobility-impaired older persons , 2000, Neurology.

[30]  M. Norton,et al.  Dementia diagnoses from clinical and neuropsychological data compared , 2000, Neurology.

[31]  W. Markesbery,et al.  White matter volumes and periventricular white matter hyperintensities in aging and dementia , 2000, Neurology.

[32]  D. Inzitari.  Age‐related white matter changes and cognitive impairment , 2000, Annals of neurology.

[33]  Matthijs Oudkerk,et al.  Cerebral white matter lesions and cognitive function: the Rotterdam Scan Study. , 2000 .

[34]  Linda Chang,et al.  Evaluation of antiretroviral drug efficacy for HIV-1 encephalitis in SCID mice , 2000, Neurology.

[35]  W R Markesbery,et al.  Periventricular White Matter Hyperintensities on MRI: Correlation With Neuropathologic Findings , 2000, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

[36]  C. DeCarli,et al.  Apolipoprotein E genotype and hippocampal asymmetry in Alzheimer's disease: a volumetric MRI study , 2000, Journal of neurology, neurosurgery, and psychiatry.

[37]  Charles DeCarli,et al.  APOE-ε4 is associated with less frontal and more medial temporal lobe atrophy in AD , 1999, Neurology.

[38]  M. Alberts,et al.  APOE genotype as a risk factor for ischemic cerebrovascular disease , 1999, Neurology.

[39]  P. Scheltens,et al.  Apolipoprotein E ϵ4 Allele, Temporal Lobe Atrophy, and White Matter Lesions in Late-Life Dementias , 1999 .

[40]  R. Mayeux,et al.  Low-density lipoprotein cholesterol and the risk of dementia with stroke. , 1999, JAMA.

[41]  W. Jagust,et al.  The Role of APOE ∊4 in Modulating Effects of Other Risk Factors for Cognitive Decline in Elderly Persons , 1999 .

[42]  F. Fazekas,et al.  MRI white matter hyperintensities , 1999, Neurology.

[43]  E. Otomo,et al.  Atherosclerosis is not implicated in association of APOE ε4 with AD , 1999, Neurology.

[44]  K. Welsh-Bohmer,et al.  APOE-ε4 count predicts age when prevalence of AD increases, then declines , 1999, Neurology.

[45]  Eric M. Reiman,et al.  Preclinical memory decline in cognitively normal apolipoprotein E–ε4 homozygotes , 1999, Neurology.

[46]  C. Jack,et al.  Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment , 1999, Neurology.

[47]  M Ashtari,et al.  Neuropsychological functioning and MRI signal hyperintensities in geriatric depression. , 1999, The American journal of psychiatry.

[48]  K. Ishii,et al.  Lack of Association of Apolipoprotein E ε4 Allele Dose with Cerebral Glucose Metabolism in Alzheimer Disease , 1998 .

[49]  B. Miller,et al.  Midlife cardiovascular risk factors, ApoE, and cognitive decline in elderly male twins , 1998, Neurology.

[50]  C. Filley,et al.  The behavioral neurology of cerebral white matter , 1998, Neurology.

[51]  J. Price,et al.  Clinicopathologic studies in cognitively healthy aging and Alzheimer's disease: relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype. , 1998, Archives of neurology.

[52]  E G Tangalos,et al.  Hippocampal atrophy and apolipoprotein E genotype are independently associated with Alzheimer's disease , 1998, Annals of neurology.

[53]  K. Blennow,et al.  A population study of apoE genotype at the age of 85: relation to dementia, cerebrovascular disease, and mortality , 1998, Journal of neurology, neurosurgery, and psychiatry.

[54]  D. Bennett,et al.  Association of memory and cognition in Alzheimer's disease with volumetric estimates of temporal lobe structures. , 1996 .

[55]  H. Soininen,et al.  SPECT and MRI analysis in Alzheimer's disease: relation to apolipoprotein E epsilon 4 allele. , 1996, Journal of neurology, neurosurgery, and psychiatry.

[56]  C. Clark,et al.  Performance of the Dementia Severity Rating Scale: A Caregiver Questionnaire for Rating Severity in Alzheimer Disease , 1996, Alzheimer disease and associated disorders.

[57]  Hans Förstl,et al.  Longitudinal Cognitive, Electroencephalographic and Morphological Brain Changes in Ageing and Alzheimer's Disease , 1996, British Journal of Psychiatry.

[58]  D R Wekstein,et al.  Linguistic ability in early life and cognitive function and Alzheimer's disease in late life. Findings from the Nun Study. , 1996, JAMA.

[59]  Simon Boniface.  Essentials of Clinical Neurophysiology , 1996 .

[60]  Hans Förstl,et al.  Brain Atrophy in Normal Ageing and Alzheimer's Disease , 1995, British Journal of Psychiatry.

[61]  J. Haxby,et al.  The effect of white matter hyperintensity volume on brain structure, cognitive performance, and cerebral metabolism of glucose in 51 healthy adults , 1995, Neurology.

[62]  M. Folstein,et al.  Alzheimer's disease in the National Academy of Sciences-National Research Council Registry of Aging Twin Veterans. III. Detection of cases, longitudinal results, and observations on twin concordance. , 1995, Archives of neurology.

[63]  J A Yesavage,et al.  Longitudinal volumetric computed tomographic analysis of regional brain changes in normal aging and Alzheimer's disease. , 1995, Archives of neurology.

[64]  Scott T. Grafton,et al.  A method to improve interrater reliability of visual inspection of brain MRI scans in dementia , 1994, Neurology.

[65]  N. Butters,et al.  The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part V. A normative study of the neuropsychological battery , 1994, Neurology.

[66]  M. Pericak-Vance,et al.  Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[67]  H. Chui,et al.  The Modified Mini-Mental State (3MS) examination. , 1987, The Journal of clinical psychiatry.

[68]  M. Folstein,et al.  Clinical diagnosis of Alzheimer's disease , 1984, Neurology.

[69]  C. P. Hughes,et al.  A New Clinical Scale for the Staging of Dementia , 1982, British Journal of Psychiatry.

[70]  T. Salthouse,et al.  The role of memory in the age decline in digit-symbol substitution performance. , 1978, Journal of gerontology.

[71]  S. Folstein,et al.  “Mini-mental state”: A practical method for grading the cognitive state of patients for the clinician , 1975 .

[72]  J Marshall,et al.  Cerebral blood flow in dementia. , 1975, Archives of neurology.

[73]  R. Reitan.  Validity of the Trail Making Test as an Indicator of Organic Brain Damage , 1958 .

[74]  K. Caldemeyer,et al.  Adult White Matter Disease , 2000 .

[75]  John Q. Trojanowski,et al.  Neurodegenerative dementias : clinical features and pathological mechanisms , 2000 .

[76]  J. Yesavage,et al.  Structural brain correlates of verbal and nonverbal fluency measures in Alzheimer's disease. , 2000, Neuropsychology.

[77]  C. V. van Veelen,et al.  Relevance of temporal lobe white matter changes in hippocampal sclerosis. Magnetic resonance imaging and histology. , 1999, Investigative radiology.

[78]  E. Tangalos,et al.  Mild Cognitive Impairment Clinical Characterization and Outcome , 1999 .

[79]  G. Fein,et al.  Tissue segmentation of the brain in Alzheimer disease. , 1997, AJNR. American journal of neuroradiology.

[80]  E. Bigler,et al.  Hippocampal volume in normal aging and traumatic brain injury. , 1997, AJNR. American journal of neuroradiology.

[81]  J. Hoffman,et al.  Neural correlates of dementia: regional brain metabolism (FDG-PET) and the CERAD neuropsychological battery. , 1994, Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists.

[82]  C. Reynolds,et al.  Wechsler memory scale-revised , 1988 .

[83]  E. Bigler.  Diagnostic Clinical Neuropsychology , 1984 .

[84]  E. Tangalos,et al.  CME Practice parameter: , 2022 .